Crispr Therapeutics shares tumble after significant earnings miss
Adam Lipson, a director at American Battery Materials, Inc. (NASDAQ:BLTH), has increased his stake in the company through a series of stock purchases. According to a recent SEC filing, Lipson acquired a total of 800 shares of common stock over two days. The transactions, which took place on March 27 and March 28, ranged in price from $6.50 to $7.99 per share, amounting to a total investment of $5,499. The purchases come as the stock has experienced a significant 23.5% decline over the past week, according to InvestingPro data.
Following these transactions, Lipson’s total ownership in the company now stands at 1,612,633 shares. These purchases reflect Lipson’s continued confidence in the company’s prospects as it operates in the mining and quarrying sector, focusing on nonmetallic minerals. With a market capitalization of $16.82 million, BLTH has shown strong momentum this year, posting a 103% year-to-date return despite currently trading above its InvestingPro Fair Value. Subscribers can access 6 additional ProTips and comprehensive financial metrics for deeper analysis.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.